908 related articles for article (PubMed ID: 22367731)
21. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
22. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
Prentice RL; Manson JE; Langer RD; Anderson GL; Pettinger M; Jackson RD; Johnson KC; Kuller LH; Lane DS; Wactawski-Wende J; Brzyski R; Allison M; Ockene J; Sarto G; Rossouw JE
Am J Epidemiol; 2009 Jul; 170(1):12-23. PubMed ID: 19468079
[TBL] [Abstract][Full Text] [Related]
23. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
[No Abstract] [Full Text] [Related]
24. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2005; 12(5):496-511; quiz 649. PubMed ID: 16145303
[TBL] [Abstract][Full Text] [Related]
25. Micronized progesterone, progestins, and menopause hormone therapy.
Hipolito Rodrigues MA; Gompel A
Women Health; 2021 Jan; 61(1):3-14. PubMed ID: 32957843
[TBL] [Abstract][Full Text] [Related]
26. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
27. Menopausal hormone therapy and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2548-56. PubMed ID: 18086757
[TBL] [Abstract][Full Text] [Related]
28. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
[TBL] [Abstract][Full Text] [Related]
29. Global consensus statement on menopausal hormone therapy.
de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
[TBL] [Abstract][Full Text] [Related]
30. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement.
; Mangione CM; Barry MJ; Nicholson WK; Cabana M; Caughey AB; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Kubik M; Li L; Ogedegbe G; Pbert L; Ruiz JM; Stevermer J; Wong JB
JAMA; 2022 Nov; 328(17):1740-1746. PubMed ID: 36318127
[TBL] [Abstract][Full Text] [Related]
31. Estrogen and progestogen therapy in postmenopausal women.
Practice Committee of American Society for Reproductive Medicine
Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
[TBL] [Abstract][Full Text] [Related]
32. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
33. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.
North American Menopause Society.
Menopause; 2002; 9(2):84-101. PubMed ID: 11875327
[TBL] [Abstract][Full Text] [Related]
34. Risks and benefits of hormone therapy: has medical dogma now been overturned?
Shapiro S; de Villiers TJ; Pines A; Sturdee DW; Baber RJ; Panay N; Stevenson JC; Mueck AO; Burger HG
Climacteric; 2014 Jun; 17(3):215-22. PubMed ID: 24654673
[TBL] [Abstract][Full Text] [Related]
35. Clinical challenges of perimenopause: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(1):5-13. PubMed ID: 10646698
[TBL] [Abstract][Full Text] [Related]
36. The role of calcium in peri- and postmenopausal women: consensus opinion of The North American Menopause Society.
North American Menopause Society
Menopause; 2001; 8(2):84-95. PubMed ID: 11256879
[TBL] [Abstract][Full Text] [Related]
37. [Hormone replacement therapy in peri- and postmenopause].
Henes M; Hübner S
Internist (Berl); 2020 Jun; 61(6):558-564. PubMed ID: 32333087
[TBL] [Abstract][Full Text] [Related]
38. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.
Shapiro S; Farmer RD; Mueck AO; Seaman H; Stevenson JC
J Fam Plann Reprod Health Care; 2011 Oct; 37(4):225-30. PubMed ID: 21642263
[TBL] [Abstract][Full Text] [Related]
39. [Latin-American position about current state of hormone therapy. Position Statement of the Group of Latin American Experts on Hormonal Therapeutic Materials].
Grupo de expertos de Latinoamérica en materia de terapia hormonal
Ginecol Obstet Mex; 2005 Apr; 73(4):205-11. PubMed ID: 21966757
[No Abstract] [Full Text] [Related]
40. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
